LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China
Open Access
- 17 March 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 26 (7), 1280-1284
- https://doi.org/10.1093/carcin/bgi071
Abstract
Esophageal carcinoma is characterized by a widely ranged incidence variation among the different geographic regions. Anyang is a county in Henan Province of North China with the highest prevalence of esophageal carcinoma. Human papillomavirus (HPV) infection has been linked to the etiology of esophageal cancer in this area. In this study, we investigated correlations of the polymorphisms at low molecular weight polypeptide ( LMP ) and transporters with antigen processing ( TAP ) genes, with the risk of esophageal carcinoma. DNA extracted from either tumor specimens or esophageal epithelial cells was used to test HPV infection. Peripheral blood lymphocyte DNA was used for LMP/TAP genotyping. Polymerase chain reaction was performed to analyze HPV infection and LMP/TAP gene polymorphisms. The combined effect of LMP/TAP gene polymorphisms and HPV infection on esophageal carcinoma was analyzed by using unconditional logistic regression models. The TAP2 codons 379 isoleucine carriers and LMP7 codons 145 lysine carriers were found to be more susceptible to esophageal carcinoma (OR = 2.74, 95% CI = 1.15–6.49, P = 0.023 for TAP2 ; OR = 2.19, 95% CI = 1.09–4.37, P = 0.027 for LMP7 ). Patients carrying homozygous LMP7/TAP2 haplotype C, which contained the glutamine at LMP7 codons 145 and the isoleucine at TAP2 codons 379, were more prone to develop esophageal carcinoma (OR = 2.96, 95% CI = 1.13–7.81, P = 0.027). An additive effect on the risk of esophageal carcinoma development was found among individuals carrying LMP7/TAP2 haplotype C and infected by HPV (OR = 4.33, 95% CI = 2.53–7.42, P < 0.0001). LMP7/TAP2 haplotype C may act as the risk factor in esophageal carcinoma development and it may influence the tumorigenesis in HPV infected individuals.Keywords
This publication has 31 references indexed in Scilit:
- TAP genes and immunityCurrent Opinion in Immunology, 2004
- Novel TAP1 polymorphisms in indigenous Zimbabweans: their potential implications on TAP function and in human diseasesHuman Immunology, 2003
- TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk☆Gynecologic Oncology, 2003
- LMP2 and LMP7 gene polymorphism in Mexican populations: Mestizos and AmerindiansGenes & Immunity, 2002
- A New Statistical Method for Haplotype Reconstruction from Population DataAmerican Journal of Human Genetics, 2001
- TAP off — tumors onImmunology Today, 1997
- TCR usage in CTLs recognizing melanoma/melanocyte antigensImmunology Today, 1995
- TAP polymorphism does not influence transport of peptide variants in mice and humansEuropean Journal of Immunology, 1995
- Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.The Journal of Experimental Medicine, 1994
- TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selectiveCell, 1993